CDK Global, Inc. 4

4 · CDK Global, Inc. · Filed Mar 10, 2017

Form 4

Period: 2017-03-08

VP & President, ARNA

Transactions

Exercise/Conversion
Common Stock
2017-03-08$20.24/sh+14,476$293,052→ 85,274.892 total
Exercise/Conversion
Common Stock
2017-03-08$21.72/sh+22,059$479,121→ 107,333.892 total
Sale
Common Stock
2017-03-08$66.47/sh−46,185$3,070,102→ 61,148.892 total
Exercise/Conversion
Stock Option (Right to Buy)
2017-03-08−14,476→ 0 total
Exercise: $20.24Exp: 2022-01-25→ Common Stock (14,476 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2017-03-08−22,059→ 0 total
Exercise: $21.72Exp: 2023-01-24→ Common Stock (22,059 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2017-03-08−9,650→ 0 total
Exercise: $17.96Exp: 2021-02-07→ Common Stock (9,650 underlying)
Exercise/Conversion
Common Stock
2017-03-08$17.96/sh+9,650$173,314→ 70,798.892 total

Footnotes (2)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple open market transactions at prices ranging from $66.30 to $66.60, inclusive. The report person undertakes to provide to CDK Global, Inc., a security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
[F2]Grant has a graded vesting schedule. Date Exercisable varied for each vesting tranche.

Documents

1 file